Semaglutide: Decoding the hype around the wei...

On February 2nd, Trump announced a trade deal with India via a social media post, with no signed agreement, no formal text. Trump says India has committed to stop buying Russian oil, purchase $500 billion in American goods, and grant zero-tariff access while the US merely reduces ...  Show more

Tamil Nadu's 234-seat assembly election hinges on an unprecedented question: can superstar Vijay's TVK disrupt the established DMK-AIADMK duopoly? Host Anirban Chowdhury talks to political analyst Sumanth Raman, who dissects the math Vijay polls around 15% vote share but may win ...  Show more

You may have heard about a new miracle weight loss drug called Ozempic. Videos have been spreading online of users claiming insane weight loss in short periods of time. Even celebrities like Kim Kardashian have been accused of using it to slim down. There's just one problem...Oze ...  Show more

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Show more

Today’s podcast is about the weight-loss drug revolution—which I believe might be one of the most important stories in the world right now. Despite all the attention weight-loss drugs are receiving, it’s possible that they might soon affect the world even more than we realize as ...  Show more

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  Show more